logo VRX

Resources

Voraxaze resources for your practice

Anish Tailor video

Watch Anish Tailor, Lead Haematology Pharmacist from UCLH, discuss his approach to managing delayed MTX elimination with glucarpidase in adult patients with lymphoma.

Watch Now

Raakhee Shah video

Watch Raakhee Shah, Lead Haematology Pharmacist from UCLH, present her thoughts on the prevention, management, and challenges with HDMTX-induced nephrotoxicity.

Watch Now

Vanessa McLelland

Watch Vanessa McLelland, Lead Paediatric Pharmacist from UHBW, present her approach on managing delayed MTX elimination with glucarpidase in paediatric patients.

Watch Now

Educational Webinar

How to manage delayed high-dose methotrexate (HDMTX) elimination in adult and paediatric haemato-oncology patients.

Thursday, 30 November 2023,17:00–18:00 GMT.

  • Dr Wendy Osborne, Haematologist, Newcastle
  • Prof Chris Fox, Haematologist, Nottingham
  • Prof Carmelo Rizzari, Paediatric Oncologist, Milan

More
Watch Now

Royal College of Emergency

Royal College of Emergency Medicine and National Poisons Information Service Guideline on Antidote Availability for Emergency Departments1
(Version 6, December 2022)

  • These drugs are held in specialist sites for supply in England.
  • Glucarpidase for methotrexate toxicity is held at Oxford Pharmacy Stores.

More

Clinical Commissioning Policy

Clinical Commissioning Policy: Glucarpidase for the urgent treatment of methotrexate induced renal dysfunction2

  • NHS England has commissioned Glucarpidase for the urgent treatment of methotrexate-induced renal dysfunction in accordance with the criteria outlined in this document.

More

Journal of Cancer research and clinical oncology

A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment
(Published October 2024)

  • Early recognition of DME is important to promptly implement appropriate treatment including, intensified hydration, high-dose leucovorin and, when appropriate, glucarpidase.

More

 

UK-VRX-2500063 Date of Preparation: December 2025